Coordinated Changes in DNA Methylation and Histone Modifications Regulate Silencing/Derepression of Luteinizing Hormone Receptor Gene Transcription

REFERENCES

• Agalioti, T., G. Chen, and D. Thanos. 2002. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111:381–392.
   PubMed Web of Science ®Google Scholar
• Ammanamanchi, S., and M. G. Brattain. 2001. 5-AzaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3. J. Biol. Chem. 276:32854–32859.
   PubMedGoogle Scholar
• Ammanamanchi, S., S.-J. Kim, L.-Z. Sun, and M. G. Brattain. 1998. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-Aza-2′-deoxycytidine. J. Biol. Chem. 273:16527–16534.
   PubMedGoogle Scholar
• Aoyama, T., T. Okamoto, S. Nagayama, K. Nishijo, T. Ishibe, K. Yasura, T. Nakayama, T. Nakamura, and J. Toguchida. 2004. Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3. J. Biol. Chem. 279:28789–28797.
   PubMed Web of Science ®Google Scholar
• Bird, A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev. 16:6–21.
   PubMed Web of Science ®Google Scholar
• Boyes, J., and A. Bird. 1991. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64:1123–1134.
   PubMed Web of Science ®Google Scholar
• Byun, D. S., M. G. Lee, K. S. Chae, B. G. Ryu, and S. G. Chi. 2001. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res. 61:7034–7038.
   PubMed Web of Science ®Google Scholar
• Catt, K. J., and Dufau, M. L. 1991. Gonadotropic hormones: biosynthesis, secretion, receptors and action, p. 105–155. In S. S. C. Yen and R. B. Jaffe (ed.), Reproductive endocrinology. W. B. Saunders Co., Philadelphia, Pa.
   Google Scholar
• Coombes, M. M., K. L. Briggs, J. R. Bone, G. L. Clayman, A. K. El-Naggar, and S. Y. Dent. 2003. Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation. Oncogene 22:8902–8911.
   PubMedGoogle Scholar
• Cosma, M. P., T. Tanaka, and K. Nasmyth. 1999. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell 97:299–311.
   PubMed Web of Science ®Google Scholar
• Cuthbert, G. L., S. Daujat, A. W. Snowden, H. Erdjument-Bromage, T. Hagiwara, M. Yamada, R. Schneider, P. D. Gregory, P. Tempst, A. J. Bannister, and T. Kouzarides. 2004. Histone deimination antagonizes arginine methylation. Cell 118:545–553.
   PubMed Web of Science ®Google Scholar
• Daujat, S., U. M. Bauer, V. Shah, B. Turner, S. Berger, and T. Kouzarides. 2002. Cross talk between CARM1 methylation and CBP acetylation on histone H3. Curr. Biol. 12:2090–2097.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Dufau, M. L. 1998. The luteinizing hormone receptor. Annu. Rev. Physiol. 60:461–496.
   PubMed Web of Science ®Google Scholar
• El-Osta, A., P. Kantharidis, J. R. Zalcberg, and A. P. Wolffe. 2002. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol. Cell. Biol. 22:1844–1857.
   PubMed Web of Science ®Google Scholar
• Fahrner, J. A., S. Eguchi, J. G. Herman, and S. B. Baylin. 2002. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res. 62:7213–7218.
   PubMed Web of Science ®Google Scholar
• Fuks, F., P. J. Hurd, D. Wolf, X. Nan, A. P. Bird, and T. Kouzarides. 2003. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278:4035–4040.
   PubMed Web of Science ®Google Scholar
• Garinis, G. A., G. P. Patrinos, N. E. Spanakis, and P. G. Menounos. 2002. DNA hypermethylation: when tumour suppressor genes go silent. Hum. Genet. 111:115–127.
   PubMed Web of Science ®Google Scholar
• Geng, Y., C. H. Tsai-Morris, Y. Zhang, and M. L. Dufau. 1999. The human luteinizing hormone receptor gene promoter: activation by Sp1 and Sp3 and inhibitory regulation. Biochem. Biophys. Res. Commun. 263:366–371.
   PubMedGoogle Scholar
• Grunstein, M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389:349–352.
   PubMed Web of Science ®Google Scholar
• Gui, C.-Y., L. Ngo, W. S. Xu, V. M. Richon, and P. A. Marks. 2004. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc. Natl. Acad. Sci. USA 101:1241–1246.
   PubMed Web of Science ®Google Scholar
• Hu, Z., L. Zhuang, X. Guan, J. Meng, and M. L. Dufau. 1997. Steroidogenic factor-1 is an essential transcriptional activator for gonad-specific expression of promoter I of the rat prolactin receptor gene. J. Biol. Chem. 272:14263–14271.
   PubMedGoogle Scholar
• Huang, L., Y. Sowa, T. Sakai, and A. B. Pardee. 2000. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Oncogene 19:5712–5719.
   PubMed Web of Science ®Google Scholar
• Jaskelioff, M., and C. L. Peterson. 2003. Chromatin and transcription: histones continue to make their marks. Nat. Cell Biol. 5:395–399.
   PubMedGoogle Scholar
• Jones, P. A., and S. B. Baylin. 2002. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3:415–428.
   PubMed Web of Science ®Google Scholar
• Jones, P. L., G. J. Veenstra, P. A. Wade, D. Vermaak, S. U. Kass, N. Landsberger, J. Strouboulis, and A. P. Wolffe. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19:187–191.
   PubMed Web of Science ®Google Scholar
• Kouzarides, T. 2002. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12:198–209.
   PubMed Web of Science ®Google Scholar
• Kuzmichev, A., and D. Reinberg. 2001. Role of histone deacetylase complexes in the regulation of chromatin metabolism. Curr. Top. Microbiol. Immunol. 254:35–58.
   PubMedGoogle Scholar
• Laird, P. W., L. Jackson-Grusby, A. Fazeli, S. L. Dickinson, W. E. Jung, E. Li, R. A. Weinberg, and R. Jaenisch. 1995. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:197–205.
   PubMed Web of Science ®Google Scholar
• Lei, Z. M., S. Mishra, W. Zou, B. Xu, M. Foltz, X. Li, and C. V. Rao. 2001. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol. Endocrinol. 15:184–200.
   PubMed Web of Science ®Google Scholar
• Li, E. 2002. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 3:662–673.
   PubMed Web of Science ®Google Scholar
• Li, J., Q. Lin, H. G. Yoon, Z. Q. Huang, B. D. Strahl, C. D. Allis, and J. Wong. 2002. Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Mol. Cell. Biol. 22:5688–5697.
   PubMedGoogle Scholar
• Ma, H., C. T. Baumann, H. Li, B. D. Strahl, R. Rice, M. A. Jelinek, D. W. Aswad, C. D. Allis, G. L. Hager, and M. R. Stallcup. 2001. Hormone-dependent, CARM1-directed, arginine-specific methylation of histone H3 on a steroid-regulated promoter. Curr. Biol. 11:1981–1985.
   PubMedGoogle Scholar
• Magdinier, F., and A. P. Wolffe. 2001. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc. Natl. Acad. Sci. USA 98:4990–4995.
   PubMedGoogle Scholar
• Milutinovic, S., S. E. Brown, Q. Zhuang, and M. Szyf. 2004. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation. J. Biol. Chem. 279:27915–27927.
   PubMed Web of Science ®Google Scholar
• Murray, P. G., G. H. Qiu, L. Fu, E. R. Waites, G. Srivastava, D. Heys, A. Agathanggelou, F. Latif, R. G. Grundy, J. R. Mann, J. Starczynski, J. Crocker, S. E. Parkes, R. F. Ambinder, L. S. Young, and Q. Tao. 2004. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma. Oncogene 23:1326–1331.
   PubMedGoogle Scholar
• Mutskov, V., and G. Felsenfeld. 2004. Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J. 23:138–149.
   PubMed Web of Science ®Google Scholar
• Nguyen, C. T., D. J. Weisenberger, M. Velicescu, F. A. Gonzales, J. C. Lin, G. Liang, and P. A. Jones. 2002. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res. 62:6456–6461.
   PubMed Web of Science ®Google Scholar
• Rao, C. V., and Z. M. Lei. 2002. Consequences of targeted inactivation of LH receptors. Mol. Cell. Endocrinol. 187:57–67.
   PubMedGoogle Scholar
• Richards, E. J., and S. C. Elgin. 2002. Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 108:489–500.
   PubMed Web of Science ®Google Scholar
• Richon, V. M., T. W. Sandhoff, R. A. Rifkind, and P. A. Marks. 2000. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc. Natl. Acad. Sci. USA 97:10014–10019.
   PubMed Web of Science ®Google Scholar
• Santos-Rosa, H., R. Schneider, A. J. Bannister, J. Sherriff, B. E. Bernstein, N. C. Emre, S. L. Schreiber, J. Mellor, and T. Kouzarides. 2002. Active genes are tri-methylated at K4 of histone H3. Nature 419:407–411.
   PubMed Web of Science ®Google Scholar
• Shin, T. H., A. J. Paterson, J. H. Grant, 3rd, A. A. Meluch, and J. E. Kudlow. 1992. 5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression. Mol. Cell. Biol. 12:3998–4006.
   PubMedGoogle Scholar
• Sowa, Y., T. Orita, S. Minamikawa-Hiranabe, T. Mizuno, H. Nomura, and T. Sakai. 1999. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res. 59:4266–4270.
   PubMed Web of Science ®Google Scholar
• Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature 403:41–45.
   PubMed Web of Science ®Google Scholar
• Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:599–606.
   PubMed Web of Science ®Google Scholar
• Suka, N., Y. Suka, A. A. Carmen, J. Wu, and M. Grunstein. 2001. Highly specific antibodies determine histone acetylation site usage in yeast heterochromatin and euchromatin. Mol. Cell 8:473–479.
   PubMed Web of Science ®Google Scholar
• Szyf, M. 2002. Utilization of antisense oligonucleotides to study the role of 5-cytosine DNA methyltransferase in cellular transformation and oncogenesis. Methods 27:184–191.
   PubMedGoogle Scholar
• Takai, D., and P. A. Jones. 2002. Comprehensive analyses of CpG islands in human chromosome 21 and 22. Proc. Natl. Acad. Sci. USA 99:3740–3745.
   PubMed Web of Science ®Google Scholar
• Tsai-Morris, C. H., Y. Geng, E. Buczko, and M. L. Dufau. 1995. Characterization of diverse functional elements in the upstream Sp1 domain of the rat luteinizing hormone receptor gene promoter. J. Biol. Chem. 270:7487–7494.
   PubMedGoogle Scholar
• Tsai-Morris, C. H., Y. Geng, X. Z. Xie, E. Buczko, and M. L. Dufau. 1994. Transcriptional protein binding domains governing basal expression of the rat luteinizing hormone receptor gene. J. Biol. Chem. 269:15868–15875.
   PubMedGoogle Scholar
• Tsai-Morris, C. H., X. Xie, W. Wang, E. Buczko, and M. L. Dufau. 1993. Promoter and regulatory regions of the rat luteinizing hormone receptor gene. J. Biol. Chem. 268:4447–4452.
   PubMedGoogle Scholar
• Wang, G., L. N. Wei, and H. H. Loh. 2003. Transcriptional regulation of mouse delta-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse delta-opioid receptor gene in Neuro2A cells. J. Biol. Chem. 278:40550–40556.
   PubMed Web of Science ®Google Scholar
• Yuan, J., R. Z. Luo, S. Fujii, L. Wang, W. Hu, M. Andreeff, Y. Pan, M. Kadota, M. Oshimura, A. A. Sahin, J. P. Issa, R. C. Bast, Jr., and Y. Yu. 2003. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res 63:4174–4180.
   PubMed Web of Science ®Google Scholar
• Zhang, F. P., M. Poutanen, J. Wilbertz, and I. Huhtaniemi. 2001. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol. Endocrinol. 15:172–183.
   PubMedGoogle Scholar
• Zhang, Y., and M. L. Dufau. 2003. Dual mechanisms of regulation of transcription of luteinizing hormone receptor gene by nuclear orphan receptors and histone deacetylase complexes. J. Steroid Biochem. Mol. Biol. 85:401–414.
   PubMedGoogle Scholar
• Zhang, Y., and M. L. Dufau. 2001. EAR2 and EAR3/COUP-TFI regulate transcription of the rat LH receptor. Mol. Endocrinol. 15:1891–1905.
   PubMedGoogle Scholar
• Zhang, Y., and M. L. Dufau. 2000. Nuclear orphan receptors regulate transcription of the gene for the human luteinizing hormone receptor. J. Biol. Chem. 275:2763–2770.
   PubMedGoogle Scholar
• Zhang, Y., and M. L. Dufau. 2003. Repression of the Luteinizing Hormone Receptor Gene Promoter by Cross Talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB. Mol. Cell. Biol. 23:6958–6972.
   PubMedGoogle Scholar
• Zhang, Y., and M. L. Dufau. 2002. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. J. Biol. Chem. 277:33431–33438.
   PubMedGoogle Scholar
• Zhang, Y., H. H. Ng, H. Erdjument-Bromage, P. Tempst, A. Bird, and D. Reinberg. 1999. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13:1924–1935.
   PubMed Web of Science ®Google Scholar
• Zhu, W. G., Z. Dai, H. Ding, K. Srinivasan, J. Hall, W. Duan, M. A. Villalona-Calero, C. Plass, and G. A. Otterson. 2001. Increased expression of unmethylated CDKN2D by 5-aza-2′-deoxycytidine in human lung cancer cells. Oncogene 20:7787–7796.
   PubMed Web of Science ®Google Scholar
• Zhu, W. G., K. Srinivasan, Z. Dai, W. Duan, L. J. Druhan, H. Ding, L. Yee, M. A. Villalona-Calero, C. Plass, and G. A. Otterson. 2003. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol. Cell. Biol. 23:4056–4065.
   PubMed Web of Science ®Google Scholar